C
Can He
Researcher at Wuhan University
Publications - 6
Citations - 1339
Can He is an academic researcher from Wuhan University. The author has contributed to research in topics: Cancer & Cervical cancer. The author has an hindex of 4, co-authored 6 publications receiving 824 citations.
Papers
More filters
Journal ArticleDOI
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.
Meng-Yuan Dai,Dianbo Liu,Dianbo Liu,Miao Liu,Fuxiang Zhou,Gui-Ling Li,Zhen Chen,Zhi-An Zhang,Hua You,Meng Wu,Qi-Chao Zheng,Yong Xiong,Hui-Hua Xiong,Chun Wang,Chang-Chun Chen,Fei Xiong,Yan Zhang,Ya-Qin Peng,Si-Ping Ge,Bo Zhen,Ting-Ting Yu,Ling Wang,Hua Wang,Yu Liu,Ye-Shan Chen,Jun-Hua Mei,Xiao-Jia Gao,Zhu-Yan Li,Li-Juan Gan,Can He,Zhen Li,Yu-Ying Shi,Yu-Wen Qi,Jing Yang,Daniel G. Tenen,Daniel G. Tenen,Li Chai,Lorelei A. Mucci,Mauricio Santillana,Mauricio Santillana,Hongbing Cai +40 more
TL;DR: In a study of 105 patients with cancer and 536 without, all with confirmed COVID-19, cancer was predictive of more severe disease, with stage IV cancer, hematologic cancer, and lung cancer being associated with worse outcomes.
Journal ArticleDOI
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multi-Center Study During the COVID-19 Outbreak
Meng-Yuan Dai,Dianbo Liu,Miao Liu,Fuxiang Zhou,Gui-Ling Li,Zhen Chen,Zhi-An Zhang,Hua You,Meng Wu,Qi-Chao Zhen,Yong Xiong,Hui-Hua Xiong,Chun Wang,Chang-Chun Chen,Fei Xiong,Yan Zhang,Ya-Qin Peng,Si-Ping Ge,Bo Zhen,Ting-Ting Yu,Ling Wang,Hua Wang,Yu Liu,Ye-Shan Chen,Jun-Hua Mei,Xiao-Jia Gao,Zhu-Yan Li,Li-Juan Gan,Can He,Zhen Li,Yu-Ying Shi,Yu-Wen Qi,Jing Yang,Daniel G. Tenen,Li Chai,Lorelei A. Mucci,Mauricio Santillana,Hongbing Cai +37 more
TL;DR: The results indicate that patients with cancer appear more vulnerable to SARS-CoV-2 outbreak, and it is extremely important that this study be disseminated widely to alert clinicians and patients.
Journal ArticleDOI
The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer.
TL;DR: HMGB1 is a useful prognostic indicator and a potential biomarker of cervical cancer and RAC1 and CDC42 may be involved in the progression of cervicalcancer migration induced by HMGB1.
Journal ArticleDOI
Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study
Niresh Thapa,Muna Maharjan,Girishma Shrestha,Narayani Maharjan,Marcia A. Petrini,Na Zuo,Can He,Jing Yang,Mengfei Xu,Caiyun Ge,Ziye Song,Hongbing Cai +11 more
TL;DR: There was a higher prevalence of HR-HPV infection among women living in Jumla than other parts of Nepal, and HPV 16, 39, 58, 33, 51, and 18 are the most prevalent genotypes in this region.
Proceedings ArticleDOI
Abstract CT406: Patients with cancer appear more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak
Meng-Yuan Dai,Dianbo Liu,Miao Liu,Fuxiang Zhou,Gui-Ling Li,Zhen Chen,Zhi-An Zhang,Hua-You,Meng Wu,Qi-Chao Zheng,Yong Xiong,Hui-Hua Xiong,Chun Wang,Chang-Chun Chen,Fei Xiong,Yan Zhang,Ya-Qin Peng,Si-Ping Ge,Bo Zhen,Ting-Ting Yu,Ling Wang,Hua Wang,Yu Liu,Ye-Shan Chen,Jun-Hua Mei,Xiao-Jia Gao,Zhu-Yan Li,Li-Juan Gan,Can He,Zhen Li,Yu-Ying Shi,Yu-Wen Qi,Jing Yang,Daniel G. Tenen,Li Chai,Lorelei A. Mucci,Mauricio Santillana,Hongbing Cai +37 more
TL;DR: The results showed COVID-19 patients with cancer had higher risks in all severe outcomes, and patients with hematological cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events.